• Users Online: 470
  • Print this page
  • Email this page
Year : 2018  |  Volume : 1  |  Issue : 3  |  Page : 99-108

Patient-reported outcome measures 2 years after treatment of small ventral hernias using a monofilament polypropylene patch covered with an absorbable hydrogel barrier on its visceral side

1 Department of General and Visceral Surgery, Antony Private Hospital, Antony, France
2 Department of General and Visceral Surgery, Private Clinic of St Omer, St Omer, France
3 Department of General and Visceral Surgery, Public Clinic of St Nazaire, St Nazaire, France
4 Department of General and Visceral Surgery, Clinique St Pierre of Perpignan, Perpignan, France

Correspondence Address:
Dr. Jean-Francois Gillion
Private Hospital of Antony, Antony
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijawhs.ijawhs_20_18

Rights and Permissions

BACKGROUND: In spite of their wide use, clinical studies on intraperitoneal ventral patches are rare, especially for VentralexTM ST (VST), recently released. MATERIALS AND METHODS: Two-year results of 108 patients operated on from a ventral hernia with VST were assessed using a patient-reported outcome measures concept. RESULTS: One hundred and eight patients (59.9 ± 14.65 years; body mass index 29.72 ± 8.14; wound healing risk factor in 49 patients) were prospectively registered. Surgery was clean in 105 (97%) or clean contaminated in 3 (3%). The defect was <4 cm in diameter in 81% of primaries and <4 cm in width in 91% of incisional ventral hernias. No postoperative complication occurred except one benign subcutaneous seroma. At 2 years, 15 patients could not be reached by the independent clinical research assistant, despite five attempts at different moments, while 93 (86%) completed the phone questionnaire. None declined to answer. Only one reoperation was mentioned. Three recurrences (two not reoperated) were identified. No bowel obstruction, wound sinus, or mesh migration was identified. Only three patients had pain, mild and less bothering than their treated hernia. Compared with the preoperative quality of life, evaluated with the same questionnaire, the improvement in these 93 patients was highly statistically significant (P < 0.001). CONCLUSION: Despite potential underestimation of recurrences and rare long-term complications, this study, the first one on this new patch, suggests that VST could be safe and effective in the treatment of small primary or incisional ventral hernias. However, further studies are needed to confirm these preliminary results.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded270    
    Comments [Add]    
    Cited by others 1    

Recommend this journal